Evidence · Journal club · continued
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question posts 91–92
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
This topic was referenced in
- Journal club: STEP 1 and the treatment-policy estimandEvidence › Journal club · 3 replies
- Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold?Evidence › Journal club · 3 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Working notes on STEP 1 rather than a conclusion. I would rather…
|
+118 | 132 | 12k | 15mo |
|
Journal club: the retatrutide phase 2 obesity paper
Journal club: the retatrutide phase 2 obesity paper — setting out what I have, and where I think it stops being reliable. Collecting what is known about retatrutide phase 2 obesity paper in one place, because…
|
+7 | 11 | 33k | 7mo |
|
Journal club: STEP 3 and the intensive behavioural therapy floor — does this still hold?
The question in the title: Journal club: STEP 3 and the intensive behavioural therapy floor — does this still hold? I will give what I have already checked below so nobody repeats it. Asking about STEP 3 on…
|
2 | 15k | 10mo | |
|
Journal club: the CagriSema phase 2 combination paper — a second dataset
Journal club: the CagriSema phase 2 combination paper — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on CagriSema phase 2 combination paper.…
|
+74 | 79 | 2.3k | 13mo |
|
Journal club: SURMOUNT-4 and continuation versus withdrawal
Journal club: SURMOUNT-4 and continuation versus withdrawal — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on SURMOUNT-4 and continuation…
|
+32 | 36 | 31k | 3mo |
Related topics — sharing the tags randomised trial, risk of bias, effect size
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Seven-day rolling means and why weekly readings mislead
Seven-day rolling means and why weekly readings mislead Writing it up because I had to work it out twice and would rather nobody else did. Posting a series rather than a conclusion, with the method first.…
|
+109 | 125 | 42k | 10h |
|
Blinding yourself: practical methods and their limits — the long version
Blinding yourself: practical methods and their limits — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Blinding yourself,…
|
+7 | 11 | 1.8k | 22h |
|
Designing a personal experiment that could change your mind
Posting this under the heading it deserves: Designing a personal experiment that could change your mind Everything below is what sits behind that. I was wrong about designing a personal experiment in a thread…
|
+2 | 6 | 695 | 6mo |
|
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one — setting out what I have, and where I think it stops being reliable. Posting a small dataset on PIONEER 6 cardiovascular…
|
+25 | 29 | 22k | 1d |
|
Selection into a registry and what it does to the estimate
Selection into a registry and what it does to the estimate — setting out what I have, and where I think it stops being reliable. Working notes on selection rather than a conclusion. I would rather post the…
|
2 | 55k | 7mo |